Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease
Whangbo et al.
Blood Advances
April 2019
Authors and Affiliates
Whangbo JS1,2,3,4, Kim HT5,6, Nikiforow S3,4, Koreth J3,4, Alho AC3,4,7, Falahee B3,4, Kim S3,4, Dusenbury K3,4, Fields MJ3,4, Reynolds CG3,4, Alyea EP 3rd3,4, Armand P3,4, Cutler CS3,4, Ho VT3,4, Antin JH3,4, Soiffer RJ3,4, Ritz J3,4
1
Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA.
2
Department of Pediatric Oncology and.
3
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston MA.
4
Harvard Medical School, Boston, MA.
5
Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
6
Harvard School of Public Health, Boston, MA; and.
7
Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.